Valuation: Simcere Pharmaceutical Group Limited

Capitalization 382.31Cr 2.98TCr 325.16Cr 301.39Cr 281.64Cr 525.03Cr 35TCr 556.49Cr 3.44TCr 1.37TCr 17TCr 1.43TCr 1.4TCr 60TCr P/E ratio 2025 *
21.1x
P/E ratio 2026 * 17x
Enterprise value 373.01Cr 2.91TCr 317.24Cr 294.05Cr 274.79Cr 512.25Cr 34TCr 542.95Cr 3.36TCr 1.33TCr 16TCr 1.4TCr 1.37TCr 59TCr EV / Sales 2025 *
3.42x
EV / Sales 2026 * 2.87x
Free-Float
29.6%
Yield 2025 *
2.4%
Yield 2026 * 2.93%
More valuation ratios * Estimated data
Dynamic Chart
1 day-1.28%
1 week-0.95%
Current month-3.68%
1 month-10.62%
3 months-7.32%
6 months-1.96%
Current year-3.68%
More quotes
1 week 11.4
Extreme 11.4
12.02
1 month 10.6
Extreme 10.6
13.02
Current year 10.6
Extreme 10.6
12.32
1 year 6.66
Extreme 6.66
15.08
3 years 4.94
Extreme 4.94
15.08
5 years 4.94
Extreme 4.94
15.08
10 years 4.94
Extreme 4.94
15.08
More quotes
Manager TitleAgeSince
Chief Executive Officer 63 17/01/2014
Director of Finance/CFO 55 19/11/2019
Chief Investment Officer 47 17/01/2022
Director TitleAgeSince
Chairman 63 08/10/2012
Director/Board Member 55 19/11/2019
Director/Board Member 46 01/11/2019
More insiders
Change 5d. change 1-year change 3-years change Capi.($)
-1.28%-0.95%+67.83%+8.16% 387.32Cr
-0.14%-2.22%-11.00%+55.52% 4.28TCr
+2.36%+3.63%+17.51%+124.30% 3.04TCr
-4.04%-5.90%-9.38%+23.76% 1.21TCr
-0.37%+1.60%-10.83%+98.51% 972.59Cr
-0.89%+0.90%+42.95%+131.33% 805.37Cr
-0.41%-6.36%+62.32%+32.66% 789.03Cr
-.--%+0.14% - - 678.76Cr
+1.04%+1.19%+43.10%-21.20% 671.95Cr
-1.48%-1.65%+30.23%+369.95% 615.35Cr
Average -0.52%-1.43%+25.86%+91.44% 1.35TCr
Weighted average by Cap. -0.03%-2.14%+11.11%+85.22%
See all sector performances

Financials

2025 *2026 *
Net sales 109.16Cr 851.24Cr 93Cr 86Cr 80Cr 149.91Cr 10TCr 158.89Cr 983.47Cr 390.44Cr 4.74TCr 409.32Cr 400.95Cr 17TCr 132.12Cr 1.03TCr 112.37Cr 104.16Cr 97Cr 181.45Cr 12TCr 192.32Cr 1.19TCr 472.58Cr 5.73TCr 495.43Cr 485.29Cr 21TCr
Net income 17Cr 134.97Cr 15Cr 14Cr 13Cr 24Cr 1.59TCr 25Cr 155.94Cr 62Cr 750.83Cr 65Cr 64Cr 2.73TCr 21Cr 166.38Cr 18Cr 17Cr 16Cr 29Cr 1.96TCr 31Cr 192.23Cr 76Cr 925.55Cr 80Cr 78Cr 3.37TCr
Net Debt -9.31Cr -73Cr -7.92Cr -7.34Cr -6.86Cr -13Cr -855.04Cr -14Cr -84Cr -33Cr -403.71Cr -35Cr -34Cr -1.47TCr -2.66Cr -21Cr -2.26Cr -2.1Cr -1.96Cr -3.66Cr -244.54Cr -3.87Cr -24Cr -9.52Cr -115.46Cr -9.98Cr -9.78Cr -419.99Cr
More financial data * Estimated data
Logo Simcere Pharmaceutical Group Limited
Simcere Pharmaceutical Group Ltd is a company engaged in research and development, production and sales of drugs. The Company's main products are generic drugs, including Bicun used for central nervous system diseases, Jepaso and Jiebaili used for oncology, as well as Yingtaiqing used for autoimmune diseases. The Company also produces various drugs, including Endostar used for oncology. The Company is also involved in providing promotion services for third-party drugs sold by medical institutions. The Company mainly conducts its businesses in the domestic market and overseas markets.
Employees
6,815
More about the company
Date Price Change Volume
23/26/23 11.53 $ -1.28% 40,57,370
22/26/22 11.68 $ -1.27% 73,15,000
21/26/21 11.83 $ +0.08% 35,70,002
20/26/20 11.82 $ +1.90% 60,70,660
19/26/19 11.60 $ -0.34% 59,55,619

Delayed Quote Hong Kong S.E., January 23, 2026 at 01:38 pm IST

More quotes
Trader
Investor
Global
Quality
ESG MSCI
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
10.30CNY
Average target price
14.45CNY
Spread / Average Target
+40.39%
Consensus

Annual profits - Rate of surprise